caspase-7 Antibodies

Santa Cruz Biotechnology provides a broad selection of caspase-7 monoclonal antibodies for research in apoptosis and cell signaling pathways. caspase-7 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Caspase-7 is a crucial executioner caspase involved in the apoptotic process, playing a significant role in the cleavage of key cellular substrates that lead to programmed cell death. Its activity is essential for maintaining cellular homeostasis and regulating immune responses. Dysregulation of caspase-7 has been implicated in various diseases, including cancer and neurodegenerative disorders, making it an important target for therapeutic intervention. Understanding caspase-7 function and regulation is vital for developing new therapeutic strategies. Researchers worldwide rely on caspase-7 monoclonal antibodies to advance their studies in cell death mechanisms and disease pathways. Current investigations focus on how caspase-7 activation influences various cellular processes and disease states. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to the scientific understanding of apoptosis and its role in human health.